key: cord-0916736-xcd3795e authors: Chen, Yong; Ma, Fubao; Xu, Yuanling; Chu, Xuhua; Zhang, Jinlin title: Incidence of acute disseminated encephalomyelitis in the Jiangsu province of China, 2008–2011 date: 2015-07-08 journal: Mult Scler J Exp Transl Clin DOI: 10.1177/2055217315594831 sha: d77e2f4df800eddf41d5b9f10859005ce352f820 doc_id: 916736 cord_uid: xcd3795e BACKGROUND: It is important to have an estimate of the incidence of acute disseminated encephalomyelitis (ADEM) because the incidence of ADEM is unknown and the outcomes undefined in China. OBJECTIVES: This study attempts to describe ADEM incidence in large Chinese populations located in four geographically different and moderately distant areas of the same province. METHODS: A retrospective investigation was conducted with ADEM patients in Nanjing, Nantong, Yancheng and Xuzhou. The survey was carried out in regions that might have received patients meeting the case definition of ADEM provided by the International Pediatric MS Study Group from 2008 to 2011. A total of 125 hospitals were included and 412 patients were identified through the hospital information systems (HIS). RESULTS: The incidence of ADEM was 0.32/100,000/year. There are two peaks on the age-specific ADEM rates curve. One is 0.77/100,000/year among 0- to 9-year-olds, the other is 0.45/100,000/year in those aged 50–59 years. The incidence rate found for ADEM in males was 0.34/100,000/year, and in females was 0.29/100,000/year. The highest incidence rate was in Nanjing (0.40/100,000/year). CONCLUSIONS: The average annual incidence of ADEM was 0.32/100,000/year. The peak age of onset was 50–59 years old and 0–9 years old. The incidence among males was insignificantly higher than that among females. There was no significant difference in incidence by seasonal variation. Acute disseminated encephalomyelitis (ADEM) is an immune-mediated central nervous system (CNS) disorder. 1 It is characterized by an acute encephalopathy with polyfocal neurological deficits. In the absence of specific biological markers the diagnosis of ADEM is still based on clinical features and magnetic resonance imaging (MRI) evidence of widespread demyelination, after ruling out other possible explanations for an acute encephalopathy. 2 In 2007 the International Pediatric Multiple Sclerosis (MS) Study Group proposed a consensus definition for ADEM for application in research and clinical settings. 3 The pathogenesis of ADEM is not fully known, but adhesion molecules, chemokines, matrix metalloproteinase, and other cell factors can play important roles in its occurrence and development. 4 Formerly, ADEM occurred particularly often in children with measles. However, the disease most often follows a nondescript viral or even bacterial infectious illness. Many identifiable infections have been associated with ADEM, such as measles, mumps, rubella, coxsackie, coronavirus, herpes, influenza A and B, hepatitis A and B, human T-lymphotropic virus-1, human immunodeficiency virus, dengue virus, or smallpox. 5 In addition to a known association with infections, vaccinations (e.g. rabies, smallpox or measles vaccines) have also been suggested to increase the risk of ADEM. 6 There have been many recent studies showing no long-term association between vaccinations and ADEM. 7 In recent years, the Expanded Program on Immunization (EPI) has been carried out in China. The type and number of vaccines administered to residents were expanded. The probability of having an abnormal reaction such as ADEM to vaccines is small, but the occurrences of such reactions increased after the EPI, causing widespread public concern. This may reduce public confidence in vaccines. When evaluating the risk of vaccines leading to ADEM or when judging whether ADEM has a causal association with vaccination, epidemiological features and population-level baseline incidence rates, in addition to clinical characteristics and disease diagnosis, must be assessed. A firm measure of the incidence of ADEM is increasingly important. ADEM is an uncommon illness and hence epidemiologic studies are complicated by small case series from limited centers. Worldwide distribution of ADEM is still unknown. 5 This study attempts to describe ADEM incidence in a selection of large Chinese populations located in four geographically different and moderately distant areas of the same province. Medical and pediatric services In China, most people receive medical technology and specialized neurological care provided by public hospitals. In general, patients who are suspected of having ADEM are taken to the hospital as emergencies, and soon after, a neurologist will be invited to take care of them. Patients younger than 16 years old who are affected by neurological diseases are usually taken to pediatric hospitals. Study population ADEM cases were selected from January 1, 2008 to December 31, 2011. The surveyed areas were Nanjing, Nantong, Yancheng and Xuzhou, which are four cities in Jiangsu province in China. Both urban and rural populations were involved in each city. Gender-specific and age-specific population numbers from 2008 to 2011 were from the local Bureau of Statistics. The population denominator ruled out the migratory labor population, which does not officially reside in these cities. The populations involved in this research and the geographical locations of the four cities are shown in Table 1 and Figure 1 . Cases from all hospitals that may have admitted ADEM patients were searched and reviewed through the hospital information systems (HIS). Cases were identified by the 10th revision of the International Classification of Diseases (ICD-10) diagnostic In all, 125 hospitals and 4,652,355 records in the four cities were surveyed. From these records, 471 ADEM cases were found in the study population. Among these 471 cases, 59 cases were ruled out owing to residence outside of the geographical areas of study. A total of 412 cases were involved in the incidence calculation. The incidence was 0.32 cases per 100,000 person-years. Age-and sex-specific incidences of ADEM are shown in Figure 2 , and the corresponding agespecific RRs, controlling for the effect of sex and location, are shown in Table 1 . For both sexes, there are two peaks on the age-specific ADEM rates curve. One is 0.77/100,000/year among children (09 years), the other is 0.45/100,000/year in 5059-year-olds. There are lower incidences in adults (4049 years) and the highest age group of !80 years. One is 0.15/100,000/year, the other is 0.12/100,000/year. For females, there is a higher incidence in the age group of 2029 years than that of 1019 years. The incidence rate found for ADEM in males was 0.34/100,000/year, which is higher than that in females (0.29/100,000/year) ( Table 1 ). The sex differential did not prove to be statistically significant. There is a sharper age-specific incidence curve in males than in females ( Figure 2 ). The variations in incidence by location, adjusted for age and sex, were 1.60-fold. The incidence rate in Nanjing was 0.40/100,000/year, with the highest RR (1.40, 95% CI 1.041.89). Yancheng was 0.25/ 100,000/year, with the lowest RR (0.84, 95% CI 0.601.17). The incidence difference for females, which was 2.1-fold, was more notable (Figure 3 ). New cases of ADEM occurred in each month throughout the whole year. The highest risk of acquiring ADEM for males was in February and, for females, was in April and November (Figure 4(a) ). The highest incidences were seen for young populations (under 40 years) in March and older populations in April (Figure 4(b) ). There was no significant difference in incidence by seasonal variation. This study was the first large-scale investigation of ADEM incidence in Jiangsu province in China, and it could help us to understand the baseline ADEM incidence in Jiangsu. This study found that incidence rates in four cities within Jiangsu province were 0.32/100,000/year, which is much higher than that in Germans between 1997 and 1999 (0.07/100,000/ year), 9 12 and similar to that in Nanchang (China). 13 These results may indicate that the differences in the incidence of ADEM among countries could be in favor of environmental factors, race factors or climate factors triggering the disease. Some of the variation in incidence is due to the different definitions of ADEM that were used in all of the studies and the different types of cases that were captured. Reportedly, ADEM can occur at any age, with higher frequency in children than adults. Predominant age of occurrence in children is 58 years, 6, 1417 or mainly in children and young people. 18 Pohl et al. reported that the incidence rate of ADEM was 0.09/ 100,000/year among children less than 10 years old and 0.03/100,000/year among children 1015 years old in Germany. 9 In Canada, children with ADEM were more likely to be younger than 10 years. 19 Previous studies on ADEM have focused on children but rarely on adults. Our study found that the highest incidence rate was among individuals 09 years old (0.77/100,000/year), and the incidence decreased with the increase of age among people less than 50 years old. But the incidence increased among people 5059 years old (0.45/100,000/year), followed by individuals 6069 years old (0.43/100,000/year). Senile ADEM, which attracts much of our attention, has rarely been reported. 20 It is probably due to: (1) differences between the elderly and young people in susceptibility or immune response to infectious agents, and (2) lack of sensitive tools to examine patients before the widespread use of MRI. 21 Some studies have reported no gender predominance in children. 10, 13, 22 Pohl et al. reported that the female-to-male ratio was balanced up to the age of 13 years, and more than twice as many girls than boys were reported in the 14-to 15-year-old group of children in Germany. 9 Our study found that males had an insignificantly higher risk of ADEM; the male/female ratio was 1.17. This frequency distribution has also been observed by others. 15, 23 A maleto-female incidence ratio that changes with advanced age may suggest differential referral, detection, or access to a neurologist. Generally, older women and men with neural disorders may be differentially referred from their households or homes to hospitals. When comparing geographical variations of the incidence of ADEM in Jiangsu, we found that the incidences from the highest to the lowest were in Nanjing, Nantong, Xuzhou and Yancheng. Such a result may be related to the level of social and economic development. Concerning the level of social and economic development, Nanjing has the highest level of social and economic development, followed by Nantong and Xuzhou, and Yancheng has the lowest level. In richer areas, there is more access to health care, more doctors, more neurologists, more beds, better medical conditions, better medical equipment and perhaps a lower rate of misdiagnosis. An absence of seasonal variation in ADEM incidence was also found in Nanchang, 13 another city in central China. This conclusion is different from San Diego, 10 Buffalo (New York, USA) 23 and the United Kingdom, 22 where ADEM occurs more frequently in the spring and in the winter. ADEM is thought to be triggered by a nonspecific preceding infection in more than 70% of cases. 14 23 The lack of obvious seasonal variation in incidence may be because the infections found most frequently to trigger this disease occur in different seasons around the globe. The concern that vaccinations could induce a small increased risk of ADEM remains controversial. A recent nested case-control study showed no longer-term association of vaccines with ADEM. The short-term increase in risk intimates that vaccines may accelerate the transition from subclinical to overt autoimmunity in cases with existing disease. 7 The relationship is not reviewed in current series. It would be pleasing if a cohort study on the association between vaccines and ADEM were carried out. Our study has several limitations. Some cases may have not been to the hospital or have been admitted to hospitals in regions outside of the surveyed areas and, as a result, the incidence would have been underestimated. The incidence rates found by retrospective studies produced slightly lower incidence rates than prospective studies. This may also contribute to an underestimate of the incidence. The duration of this survey was too short to discover long-term trends in the incidence of ADEM. Our findings provide a rough estimate of baseline AEDM incidence in four large populations in parts of Jiangsu province in China and provide useful information for potential epidemiological surveillance of ADEM, which will be carried out in the near future. Our findings also provide information for further studies assessing the effects of potential risk factors, such as immunizations or infections. It would be satisfactory if future investigators carry out studies for a longer period of time to ensure the discovery of a long-term trend in the incidence rate of ADEM. Acute disseminated encephalomyelitis (ADEM): Its diagnostic criteria and therapy Acute disseminated encephalomyelitis The magnetic resonance imaging appearance of monophasic acute disseminated encephalomyelitis: An update post application of the 2007 consensus criteria Advances in molecular pathogenesis of acute disseminated encephalomyelitis Acute disseminated encephalomyelitis Acute disseminated encephalomyelitis Vaccines and the risk of multiple sclerosis and other central nervous system demyelinating diseases Consensus definitions proposed for pediatric multiple sclerosis and related disorders Paediatric multiple sclerosis and acute disseminated encephalomyelitis in Germany: Results of a nationwide survey Acute disseminated encephalomyelitis in childhood: Epidemiologic, clinical and laboratory features Acute disseminated encephalomyelitis: A 10-year cohort study in Thai children Acute disseminated encephalomyelitis: Clinical and pathogenesis features Epidemiological characteristics of acute disseminated encephalomyelitis in Nanchang, China: A retrospective study Clinical and neuroradiologic features of acute disseminated encephalomyelitis in children Acute disseminated encephalomyelitis: A long-term follow Translational and Clinical 6 www.sagepub.com/msjetc up study of 84 pediatric patients Acute disseminated encephalomyelitis in children: Outcome and prognosis Descriptive study of acute disseminated encephalomyelitis and evaluation of functional outcome predictors Clinical characteristics of 36 cases of acute disseminated encephalomyelitis Incidence of acquired demyelination of the CNS in Canadian children Acute disseminated encephalomyelitis: A follow-up study of 40 adult patients Acute disseminated encephalomyelitis in middle-aged or elderly patients Acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in children Acute disseminated encephalomyelitis in children The authors greatly appreciate the fieldwork of the following institutions: the Nanjing CDC, Nantong CDC, Yancheng CDC and Xuzhou CDC. The authors have also greatly benefited from the China CDC. None declared.